{
    "clinical_study": {
        "@rank": "68655", 
        "arm_group": [
            {
                "arm_group_label": "Investigational Nutrition", 
                "arm_group_type": "Experimental", 
                "description": "Starting between post menstrual age (PMA) 34 0/7 to 38 6/7 weeks, infants in the Investigational Nutrition group will receive vitamin D drops that are added to transitional formula daily through hospital discharge and at home until the outpatient follow-up visit at 52 weeks PMA."
            }, 
            {
                "arm_group_label": "Routine Nutrition", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Starting between post menstrual age (PMA) 34 0/7 to 38 6/7 weeks, infants in the Routine Nutrition group will receive placebo drops that are added to transitional formula daily through hospital discharge and at home until the outpatient follow-up visit at 52 weeks PMA."
            }
        ], 
        "brief_summary": {
            "textblock": "Transitional formulas (22 kcal/oz) are recommended for infants less than 35 weeks gestation\n      at birth. However, few data are available related to follow-up of infants receiving these\n      formulas who were 28-34 weeks gestation at birth.\n\n      Primary hypothesis: Provision of supplemental vitamin D to a transitional formula will lead\n      to higher serum 25-hydroxyvitamin D (25-OHD) levels and no infant with a serum 25-OHD less\n      than 20 ng/mL when assessed at approximately 52 weeks post-menstrual age (PMA)."
        }, 
        "brief_title": "Effect of Vitamin D in Diets of Preterm Infants", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Premature Infants", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Born at 28 0/7 to 34 6/7 weeks PMA and 1000-2250 g birth weight.\n\n          -  Currently 34 0/7 to 38 6/7 weeks post-menstrual age at time of consent.\n\n          -  Born at Texas Children's (including Pavilion for Women) or Methodist campus hospitals\n             or transferred within 48 hours of birth.\n\n          -  Care expected to be provided at one of these institutions until discharge home.\n\n          -  Any initial feeding will be permitted, but expected to transition to primarily (80%\n             of feeds or up to 2 breast milk feeds per day) infant formula by 38 6/7 weeks PMA or\n             hospital discharge, whichever comes first.\n\n          -  Able to tolerate 22 kcal/oz transitional formula and receive a volume of at least 130\n             mL/kg/day total feeding volume.\n\n          -  No longer receiving any form of mechanical ventilation or diuretics. Low flow nasal\n             cannula (< \u00bc LPM) will be permitted if it is anticipated this will be discontinued\n             before hospital discharge.\n\n        Exclusion Criteria:\n\n          -  Bronchopulmonary dysplasia (BPD) requiring daily use of diuretics beyond 38 6/7 weeks\n             PMA (or hospital discharge, whichever comes first) and > 22 kcal/oz concentration\n             formula beyond 38 6/7 weeks PMA.\n\n          -  Major congenital anomalies, history of proven Stage 2 or above NEC, or severe feeding\n             intolerance.\n\n          -  Caloric density greater than 22 kcal/oz.\n\n          -  Higher order multiples (However, twins are acceptable. Twins will be randomized\n             together. Only data from 1 twin picked at random will be used in the final analyses.)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01698840", 
            "org_study_id": "H-31433"
        }, 
        "intervention": {
            "arm_group_label": "Investigational Nutrition", 
            "intervention_name": "Vitamin D", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Vitamin D", 
            "Transitional Formula"
        ], 
        "lastchanged_date": "May 17, 2013", 
        "link": {
            "description": "Children's Nutrition Research Center", 
            "url": "http://www.kidsnutrition.org"
        }, 
        "location": {
            "contact": {
                "email": "kelih@bcm.edu", 
                "last_name": "Keli M Hawthorne, MS, RD", 
                "phone": "713-798-7085"
            }, 
            "facility": {
                "address": {
                    "city": "Houston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77030"
                }, 
                "name": "Baylor College of Medicine / Texas Children's Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Steve Abrams, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Keli M Hawthorne, MS, RD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Amy Hair, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Lori Pandya, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Adel Elhennawy, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "An Evaluation of the Effects of Two Levels of Vitamin D in Infants Fed Preterm or Transitional Formula on Serum 25-Hydroxyvitamin D and Bone Status in Preterm Infants: A Double-Blind, Randomized Controlled Trial", 
        "overall_contact": {
            "email": "kelih@bcm.edu", 
            "last_name": "Keli Hawthorne, MS, RD, LD", 
            "phone": "713-798-7085"
        }, 
        "overall_official": {
            "affiliation": "Baylor College of Medicine", 
            "last_name": "Steven Abrams, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from Baseline in Serum 25-hydroxyvitamin D (25-OHD) level at 52 weeks post-menstrual age", 
            "safety_issue": "No", 
            "time_frame": "Last 7 days of hospitalization and at 52 weeks post-menstrual age (PMA)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01698840"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Baylor College of Medicine", 
            "investigator_full_name": "Steve Abrams, MD", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Change from Baseline in Alkaline phosphatase activity at 52 weeks post-menstrual age", 
            "safety_issue": "No", 
            "time_frame": "Last 7 days of hospitalization and at 52 weeks PMA"
        }, 
        "source": "Baylor College of Medicine", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "USDA Beltsville Human Nutrition Research Center", 
                    "agency_class": "U.S. Fed"
                }, 
                {
                    "agency": "Mead Johnson Nutrition", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Baylor College of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}